CLOV
Clover Health Investments, Corp. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth +8.3% ·
share flow +6.0% ·
net new positions +7.7%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 128.61M | $672.46M | +12 | −6 |
| Q1 2026 | 82 | +5 | 113.55M | $200.08M | +10 | −5 |
| Q4 2025 | 76 | -1 | 119.92M | $281.85M | n/a | −1 |
| Q3 2025 | 14 | -2 | 85.90M | $262.85M | n/a | −2 |
| Q2 2025 | 13 | +1 | 91.13M | $254.25M | +1 | n/a |
| Q1 2025 | 9 | 0 | 31.30M | $112.39M | +2 | −2 |
| Q4 2024 | 9 | 0 | 25.46M | $80.20M | n/a | n/a |
| Q3 2024 | 8 | +1 | 20.89M | $58.90M | +2 | −1 |
| Q2 2024 | 7 | n/a | 19.27M | $23.70M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 30.40M | n/a | $84.81M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 2 | The Vanguard Group ✦ (passive) | 24.25M | n/a | $67.65M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Renaissance Technologies ✦ | 10.49M | -4.8% | $29.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 9.84M | +95.7% | $27.47M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (passive) | 7.51M | +156.5% | $20.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 3.53M | +103.6% | $9.85M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 3.52M | -23.0% | $9.83M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.06M | -81.8% | $2.95M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 350.26K | +129.7% | $978,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Gotham Asset Management ✦ | 105.60K | +158.0% | $294,632 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 46.96K | New | $131,016 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 17.75K | +30.8% | $49,533 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Fidelity (FMR) ✦ | 8.16K | n/a | $22,779 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $131,016 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 207 holders, 127.13M shares, $218.62M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.01K sh · $9,288
Officer · 8.75K sh · $38,675
Officer, Director · 318.81K sh · $1.34M
Officer · 1.92K sh · $8,760
Officer · 3.17K sh · $14,709
Officer · 300.00K sh · $1.42M
Officer · 9.27K sh · $44,325
Officer · 6.85K sh · $32,724
Officer · 20.00K sh · $103,200
Officer · 17.77K sh · $78,032
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology